A Nanaimo company has been granted a licence to test and analyze psychedelic drugs.

Salvation Botanicals鈥� Nanaimo lab has been granted a controlled drugs and substances dealer鈥檚 licence to test psychedelics such as psilocybin, mescaline and MDMA, said Michael Tan, the company鈥檚 CEO, in an e-mail to the News Bulletin.

The licence authorizes possession, testing, sale, sending, transportation and delivery of psilocybin, psilocin, mescaline, dimethyltryptamine (DMT), and methylenedioxyamphetamine (MDMA), according to a press release.

Although the licence authorizes sale of the psychedelics, Tan noted in the e-mail that at this point, the drugs can only be provided to those authorized to conduct research and development and clinical trials.

Salvation has partnered with Vancouver-based Numinus, which according to the release 鈥渁ims to facilitate guided psychedelic therapy for individuals suffering from mental health issues, addiction, and trauma.鈥�

鈥淧sychedelics for the treatment of mental health issues is a topic of high interest now, and Salvation is proud to be at the forefront of this space,鈥� Tan said, adding in the release that Salvation Botanicals is 鈥渟trategically positioned to become a leader in controlled substances testing in Canada by providing scientific expertise and a commitment to our partner鈥檚 success through an efficient and consultative approach.鈥�

Tan noted that a will begin soon through the B.C. Centre on Substance Use.

鈥淟ooking ahead beyond the Phase 3 clinical trial stage is the prospect of public use,鈥� he said.

He said Numinus is positioning itself as a channel for psychedelics-based therapy at clinics it plans to set up, and at that point, Salvation could potentially participate through research and development, testing and manufacturing.

editor@nanaimobulletin.com
Like us on and follow us on